Development of a chemiluminescent screening assay for detection of vascular endothelial growth factor receptor 1 ligands

Analytical Biochemistry

Volumn 366, Issue 1, 2007, Pages 108-110

  Goncalves, Victor ^a,b   Gautier, Benoit ^a,b   Garbay, Christiane ^a,b   Vidal, Michel ^a,b   Inguimbert, Nicolas ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

SCREENING ASSAYS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR;

CHEMISTRY;

ACETYL LYSYLLEUCYLTHREONYLTRYPTOPHYLGLUTAMINYLGLUTAMYLLEUCYLTYROSYLGLUTAMINYLLEUCYLLYSYLTYROSYLLYSYLGLYCYLISOLEUCYL AMIDE; ASPARAGINYLGLYCYLTYROSYLGLUTAMYLLEUCYLGLUTAMYLTRYPTOPHYLTYROSYLSERYLTRYPTOPHYLVALYLTHREONYLHISTIDYLGLYCYLMETHIONYLTYROSYL AMIDE; IODINE 125; LIGAND; NEUROPILIN 1; STREPTAVIDIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 ANTAGONIST; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 ANTIBODY; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN ANTIBODY; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; BINDING AFFINITY; BIOTINYLATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG BINDING; HUMAN; HUMAN CELL; IC 50; ISOTOPE LABELING; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SCREENING;

EID: 34248544959     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.03.027     Document Type: Article

References (14)

1. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9 (2003) 653-660
2. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
3. Olsson A.K., Dimberg A., Kreuger J., and Claesson-Welsh L. VEGF receptor signalling: In control of vascular function. Nat. Rev. Mol. Cell. Biol. 7 (2006) 359-371
4. Guttmann-Raviv N., Kessler O., Shraga-Heled N., Lange T., Herzog Y., and Neufeld G. The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett. 231 (2006) 1-11
5. Luttun A., Autiero M., Tjwa M., and Carmeliet P. Genetic dissection of tumor angiogenesis: Are PlGF and VEGFR-1 novel anti-cancer targets?. Biochim. Biophys. Acta 1654 (2004) 79-94
6. D'Andrea L.D., Del Gatto A., Pedone C., and Benedetti E. Peptide-based molecules in angiogenesis. Chem. Biol. Drug Des. 67 (2006) 115-126
7. Binetruy-Tournaire R., Demangel C., Malavaud B., Vassy R., Rouyre S., Kraemer M., Plouet J., Derbin C., Perret G., and Mazie J.C. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J. 19 (2000) 1525-1533
8. D'Andrea L.D., Iaccarino G., Fattorusso R., Sorriento D., Carannante C., Capasso D., Trimarco B., and Pedone C. Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide. Proc. Natl. Acad. Sci. USA 102 (2005) 14215-14220
9. An P., Lei H., Zhang J., Song S., He L., Jin G., Liu X., Wu J., Meng L., Liu M., and Shou C. Suppression of tumor growth and metastasis by a VEGF-R1 antagonizing peptide identified from a phage display library. Intl. J. Cancer 111 (2004) 165-173
10. Perret G.Y., Starzec A., Hauet N., Vergote J., Le Pecheur M., Vassy R., Leger G., Verbeke K.A., Bormans G., Nicolas P., Verbruggen A.M., and Moretti J.L. In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1. Nuclear Med. Biol. 31 (2004) 575-581
11. Barleon B., Totzke F., Herzog C., Blanke S., Kremmer E., Siemeister G., Marme D., and Martiny-Baron G. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J. Biol. Chem. 272 (1997) 10382-10388
12. de Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., and Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255 (1992) 989-991
13. El-Mousawi M., Tchistiakova L., Yurchenko L., Pietrzynski G., Moreno M., Stanimirovic D., Ahmad D., and Alakhov V. A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library. J. Biol. Chem. 278 (2003) 46681-46691
14. Tirand L., Frochot C., Vanderesse R., Thomas N., Trinquet E., Pinel S., Viriot M.L., Guillemin F., and Barberi-Heyob M. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells. J. Control Release 111 (2006) 153-164